Peigang Yang

Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Ping’an Ding, Honghai Guo, Chenyu Sun et al. · BMC Gastroenterology · 2022 · 167 citations · Full text

Medicine, Oncology, Pharmacology +17

HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a

Qun Zhao, Yong Li, Bibo Tan et al. · PLoS ONE · 2015 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial

Honghai Guo, Ping’an Ding, Chenyu Sun et al. · Frontiers in Oncology · 2022 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study

Ping’an Ding, Peigang Yang, Chenyu Sun et al. · Frontiers in Oncology · 2022 · 42 citations · Full text

Medicine, Immunology, Oncology +17

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial

Qun Zhao, Changhong Lian, Zhibin Huo et al. · Cancer Medicine · 2020 · 40 citations · Full text

Medicine, Oncology, Perioperative Medicine +13